Friday, 17 Nov 2017

You are here

Linkage Between Gut and Joint Immunity in Rheumatoid Arthritis

Pianta, et al have published their findings in the Journal of Clinical Investigation showing that two novel autoantigens, GNS and FLNA, are highly expressed in synovium and share a sequence homology with gut microbesa; thereby providing a potential link between gut mucosal and joint immunity in rheumatoid arthritis (RA). 

Researchers used discovery-based proteomics to detect HLA-DR–presented peptides in synovia or peripheral blood mononuclear cells from RA patients. They found that two autoantigens, N-acetylglucosamine-6-sulfatase (GNS) and filamin A (FLNA), yielded effective T and B cell antigen specific responses (52% and 56%, respectively).

GNS and FLNA are highly expressed in synovia. GNS appeared to be citrullinated, and GNS antibody values correlate with ACPA levels. FLNA was different and did not show the same results.

The GNS peptide has marked sequence homology with epitopes from Prevotella sp. and Parabacteroides sp.

FLNA peptide has homology with epitopes from Prevotella sp. and Butyricimonas sp.

Reactivity to either GNS or FLNA was associated with reactivity to the corresponding microbial peptides.

Also, binding of these self- and microbial peptides and their responses were more common in RA patients with SE alleles.

The homology and cross reactivity of these two self-proteins and corresponding gut microbes may provide a link between mucosal and joint immunity in patients with RA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Stroke Increased in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic, inflammatory disease with systemic effects beyond the joints. While RA patients are known to have signficantly higher risks for cardiovascular disease and venous thromboembolic events, an association with stroke (CVA) is unclear.

A study claims data from Israel analyzed 11,782 RA patients and 57,973 age- and gender-matched controls.

Comparative Risk of Biologic Therapies in RA Patients Undergoing Elective Arthroplasty

During today’s plenary session Micheal D. George, et al. presented results of a study that sought to compare risk of post-op infections in RA patients undergoing arthroplasty exposed to biologic DMARDs versus methotrexate.

High Volume Lyme Disease Reporting in Low Incidence Arkansas

Even though Arkansas lies on the edge of the geographic range of the principal Lyme disease tick vector, Ixodes scapularis, the risk for Lyme infection is low, and no confirmed Lyme disease cases were reported in Arkansas during 2008–2014 (1)

RABBIT Risk Scores are Higher in ICU-Admitted RA Patients

The German Rheumatoid Arthritis Biologics Registry (RABBIT) has developed an infectious risk calculator that can project a patient's risk of serious infection in the next 6 months based on several key factors - age, Prior DMARDs, prednisone dose, comorbidities and the biologic intended for use.  (This can be found at http://www.biologika-register.de

Does Birth Control or Breastfeeding Reduce RA Risk?

 Researchers have reported their case-control study using the Swedish Epidemiological Investigation of RA study (2641 cases/4251 controls) to examine  the influence of oral contraceptive (OC) use or breastfeeding on the risk of rheumatoid arthritis (RA).